Article

Research Updates in Gout and Hyperuricemia

Learn about findings from recent studies of gout, crystalline arthritis, and hyperuricemia.

Created by the Cleveland Clinic, “Advances in Gout and Other Crystal Diseases” is a CME-accredited webcast approved for 0.25 AMA PRA Category 1 Credits. In this 15-minute video, Brian Mandell, MD, PhD, Professor and Chairman, Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Department of Rheumatic and Immunologic Diseases, Center for Vasculitis Care and Research, reviews key studies relating to crystalline arthritis and hyperuricemia, examines an anti-IL1 approach to treating acute gout attacks, and describes the role of the kidney in controlling serum urate levels and potential approaches to treating hyperuricemia.

Click here to access this third-party webcast resource.

Related Videos
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
MeiLan Han, MD: Discussing Updates on Dupilumab, Ensifentrine in 2025 GOLD Report
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.